Lassa Fever Vaccine Development
Driving R&D for endemic disease control.
Bloom Public Health provided strategic scientific input to support ongoing efforts toward the development of a Lassa fever vaccine.
Case Study
Lassa Fever Vaccine Development – Technical Support
Geographic Coverage:
Nigeria, Sierra Leone, Benin Republic, Guinea, and Liberia
The Lassa Fever Vaccine Coalition Project is a regional health security initiative funded by CEPI to accelerate the development, access, introduction, and uptake of a safe and effective Lassa Fever vaccine across West Africa.
The project seeks to strengthen the West African Health Organization (WAHO) as the regional secretariat for the Lassa vaccine ecosystem, enabling coordinated action among governments, researchers, development partners, civil society organizations, and technical stakeholders.
Through strategic advocacy, knowledge management, stakeholder engagement, evidence generation, and policy support, the project aims to create an enabling environment for vaccine preparedness and equitable access across coalition countries.
Bloom Public Health serves as a member of the Coalition Secretariat Partners (CSP), supporting regional coordination, stakeholder engagement, policy dialogue, and evidence-based decision-making.
Key Outcomes
Achieved
Achieved
- Strengthened WAHO's capacity to serve as the regional coordinating body for the Lassa Fever vaccine ecosystem in West Africa.
- Established and supported regional and country-level coalitions to improve coordination among governments, technical partners, researchers, and civil society organizations.
- Enhanced stakeholder awareness and engagement around Lassa Fever vaccine development, introduction, and access strategies.
- Facilitated knowledge sharing, evidence dissemination, and advocacy efforts to support informed decision-making on vaccine preparedness and deployment.
- Supported the development of country-specific and regional recommendations for vaccine access, introduction, and delivery.
- Promoted collaboration among public health institutions, policymakers, donors, and implementing partners across five West African countries.
- Contributed to strengthening regional preparedness and health security systems for future Lassa Fever vaccine introduction and scale-up.
- Advanced the adoption of evidence-based policies and strategies to improve equitable vaccine access and uptake across the region.
Key Outcomes Achieved
Reach Us Today!
Every conversation is the beginning of a partnership that strengthens systems, improves lives, and builds continental resilience.
Reports
